Ago, Kentaro
Nagoshi, Narihito http://orcid.org/0000-0001-8267-5789
Imaizumi, Kent http://orcid.org/0000-0002-3565-5248
Kitagawa, Takahiro
Kawai, Momotaro http://orcid.org/0000-0003-3254-0020
Kajikawa, Keita
Shibata, Reo
Kamata, Yasuhiro
Kojima, Kota
Shinozaki, Munehisa
Kondo, Takahiro
Iwano, Satoshi
Miyawaki, Atsushi
Ohtsuka, Masanari
Bito, Haruhiko http://orcid.org/0000-0001-6315-9594
Kobayashi, Kenta http://orcid.org/0000-0002-7389-3693
Shibata, Shinsuke
Shindo, Tomoko
Kohyama, Jun
Matsumoto, Morio
Nakamura, Masaya
Okano, Hideyuki http://orcid.org/0000-0001-7482-5935
Article History
Received: 12 September 2021
Accepted: 18 July 2022
First Online: 10 August 2022
Competing interests
: M.N. declares a consultancy role with K-Pharma and research funding from RMic, Hisamitsu. H.O. declares a leadership position at the Keio University Graduate School of Medicine and is a compensated scientific consultant for San Bio Co., Ltd, and K Pharma Inc. All the other authors declare no competing financial interests.